COMUNICAZIONI ORALI SABATO 24 E DOMENICA 25 OTTOBRE 2020
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
GUIDO ADOLFO CESARE LUIGI NICOLA
BACCELLI FERRATA FRUGONI CONDORELLI DIOGUARDI
COMUNICAZIONI ORALI
SABATO 24 E DOMENICA 25 OTTOBRE 2020
SABATO 24 OTTOBRE 2020 - SALA 1 SABATO 24 OTTOBRE 2020 - SALA 1
12.30 COMUNICAZIONI ORALI TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) IS
Moderatori: Antonio Cittadini (Napoli), Chiara Pes (Sassari) RELATED TO RESIDUAL THROMBOXANE DEPENDENT
EFFECTS OF EMPAGLIFLOZIN ON MYOCARDIAL PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES
METABOLIC RATE OF GLUCOSE ESTIMATED THROUGH MELLITUS RECEIVING LOW DOSE ASPIRIN
CARDIAC 18FDG PET IN PATIENTS WITH TYPE 2 DIABETES Simeone P.G.1, Tripaldi R.1, Ciotti S.1, Liani R.1, Cavalca V.2,
Succurro E.1, Pedace E.1, Papa A.2, Vizza P.1, Veltri P.1, Perticone Camera M.2, Tremoli E.3, Cipollone F.1, Santilli F.1
1Department of Medicine and Aging, Center for Advanced
F.1, Cascini G.L.2, Sesti G.3
1Department of Medical and Surgical Sciences, University Magna Studies and Technology (CAST), University “G. d’Annunzio” of
Graecia of Catanzaro; 2Department of Experimental and Clinical Chieti-Pescara, 66100 Chieti, Italy; 2Monzino Cardiology
Medicine, Magna Graecia University of Catanzaro; 3Department Center, IRCCS, Milan, Italy; 3Monzino Cardiology Center,
of Clinical and Molecular Medicine, University of Rome-Sapienza IRCCS, Milan, Italy
MANP IN SUBJECTS WITH HYPERTENSION AND METABOLIC
ASSOCIATION BETWEEN ATHEROSCLEROTIC BURDEN AND SYNDROME: A NOVEL ATRIAL NATRIURETIC PEPTIDE-BASED
GUT-DERIVED LIPOPOLYSACCHARIDES POTENTIAL THERAPY FOR CARDIOMETABOLIC DISEASE
Orlando F.1, Loffredo L.1, Ivanov V.2, Ciobanu N.2, Deseatnicova McKie P.M.1, Iyer S.R.1, Scott C.2, Bailey K.2, Johnson B.K.2,
E.3, Gutu E.4, Mudrea L.3, Ivanov M.2, Nocella C.5, Cammisotto Benike S.1, Horng H.C.1, Miller W.3, Volpi R.4, Cabassi A.4,
V.1, Pannunzio A.1, Palumbo I.1, Cosenza M.1, Paraninfi A.1, Burnett JC Jr1, Cannone V.5
Ciacci P.1, Bartimoccia S.5, Carnevale R.6, Violi F.5 1Cardiorenal Research Laboratory, Division of Circulatory
1Department of Clinical, Internistic, Anaesthetic and Failure, Department of Cardiovascular Medicine, Mayo Clinic,
Cardiovascular Sciences, Sapienza University, Rome, Italy.; Rochester, MN, USA; 2Division of Biomedical Statistics and
2Moldavian Research Institute of Cardiology, Chisinau, Republic Informatics, Mayo Clinic, Rochester, MN, USA; 3Department of
of Moldova; 3Department of Rheumatology and Nephrology, Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA;
Nicolae Testemitanu State University of Medicine and 4Clinica e Terapia Medica, Dipartimento di Medicina e
Pharmacy, Chisinau, Republic of Moldova, Chisinau, Republic of Chirurgia, Università di Parma, Parma, Italy; 5Clinica e Terapia
Moldova; 43rd Department of General Surgery, Nicolae Medica, Dipartimento di Medicina e Chirurgia, Università di
Testemitanu State University of Medicine and Pharmacy, Parma, Parma, Italy and Cardiorenal Research Laboratory,
Chisinau, Republic of Moldova, Chisinau, Republic of Moldova; Division of Circulatory Failure, Department of Cardiovascular
5Department of Clinical, Internistic, Anaesthetic and Medicine, Mayo Clinic, Rochester, MN, USA
Cardiovascular Sciences, Sapienza University, Rome, Italy;
6Department of Medical-Surgical Sciences and Biotechnologies,
Sapienza University of Rome, Latina, Italy
SABATO 24 OTTOBRE 2020 - SALA 1 SABATO 24 OTTOBRE 2020 - SALA 2
INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 12.30 COMUNICAZIONI ORALI
HAVE A COMPROMISED MYOCARDIAL MECHANO- Moderatori: Riccardo Volpi (Parma), Matteo Traversa (Torino)
ENERGETIC EFFICIENCY CORRELATION BETWEEN CARDIOVASCULAR RISK AND
Fiorentino T.V.1, Pultrone S.1, Miceli S.1, Succurro E.1, Sciacqua DISEASE ACTIVITY SCORES IN A COHORT OF PATIENTS
A.1, Andreozzi F.1, Sesti G.2 WITH SYSTEMIC LUPUS ERYTHEMATOSUS
1Department of Medical and Surgical Sciences, University
Cordeddu W., Depau C., Del Giacco S.R., Firinu D.
Magna Graecia of Catanzaro; 2Department of Clinical and Dipartimento di scienze Mediche e Sanità Pubblica, Università
Molecular Medicine, University Sapienza of Rome degli Studi di Cagliari
ACCUMULATING LONG-TERM METABOLIC SIDE EFFECTS SUPERIORITY OF INTERFERON-BASED OVER INTERFERON-
FROM COVID-19 LOCKDOWN. LOOKING AT WEIGHT GAIN, FREE THERAPY ON IMMUNOLOGIC AND CLINICAL
LIFESTYLES, AND THREATS TO WORLD OUTCOMES OF HCV-CURED CRYOGLOBULINEMIA
Shanmugam, H., Di Palo, D.M., Molina-Molina, E., Zingarelli, Colantuono S., Marrapodi R., Del Padre M., Collalti G., Garzi G.,
R.G., Pugliese, S., Di Ciaula, A., Portincasa, P. De Santis A., Fiorilli M., Basili S., Visentini M., Casato M.
Clinica Medica “A. Murri”, Department of Biomedical Sciences 1Department of Translational and Precision Medicine, Sapienza
and Human Oncology, University of Bari ‘Aldo Moro’, Bari, Italy University of Rome, Italy
SWITCH OR SWAP STRATEGY IN TAKAYASU ARTERITIS
PATIENTS FAILING TNFA (TNFI) INHIBITORS?
Campochiaro C.1, Tomelleri A.1, Galli E.2, Cocchiara E.2,
Sartorelli S.1, Muratore F.2, Catanoso M.G.2, Baldissera E.1,
Ravelli A.3, Salvarani C.1, Dagna L.1
1Unit of Immunology, Rheumatology, Allergy and Rare
Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele
University; 2Rheumatology Unit, Department of Specialistic
Medicine, Azienda USL-IRCCS di Reggio Emilia, Italy; 3Istituto
Giannina Gaslini, Genova, Italy
SABATO 24 OTTOBRE 2020 - SALA 2 SABATO 24 OTTOBRE 2020 - SALA 3
THE PATTERN OF CD26 EXPRESSION ON CIRCULATING T 12.30 COMUNICAZIONI ORALI
LYMPHOCYTES IS ALTERED IN PATIENTS WITH IDIOPTAHIC Moderatori: Stefano Del Giacco (Cagliari), Rosanna Villani (Foggia)
INFLAMMATORY MYOPATHIES PRE-COVID-19 PNEUMONIA WERE NOT CHARACTERIZED
De Lorenzo R.1, Sciorati C.2, Monno A.2, Canti V.3, Tronci S.1, BY “ATYPICAL” MANIFESTATIONS
Calvisi S.3, Conte C.4, Manfredi A.5, Previtali S.6, Rovere Querini P.5 Di Stefano M., Garolfi M., Pagani E., Miceli E., Mengoli C.,
1Vita-Salute San Raffaele University; 2San Raffaele Scientific
Lapia F., Bonaso V., Di Sabatino A.
Institute; 3San Raffaele Hospital; 4San Raffaele Hospital, Vita- Internal Medicine Unit, IRCCS S. Matteo Hospital, University of
Salute San Raffaele University; 5San Raffaele Hospital, San Pavia, Italy
Raffaele Scientific Institute, Vita-Salute San Raffaele University;
6San Raffaele Hospital, San Raffaele Scientific Institute A CLINICAL RISK SCORE TO PREDICT SEVERE OUTCOME IN
PATIENTS HOSPITALIZED FOR COVID-19: THE SIMI SCORE.
RAPID MOLECULAR TESTS FOR GRAM-NEGATIVE Ageno W.1, Cogliati C.2, Girelli D.3, Pizzolo F.3, Olivieri O.3,
BACTEREMIA IN THE ERA OF MULTI-RESISTANT Cattaneo M.4, Tombolini E.4, Benetti A.5, Corradini E.6,
INFECTIONS: A MATTER OF TIME. Pietrangelo A.6
Da Prat V.1, Galli L.2, Cichero P.3, Castiglioni B.2, Oltolini C.2, 1Dipartimento di Medicina e Chirurgia, Università degli Studi
Tassan Din C.2, Andolina A.2, Poli A.2, Moro M.4, Ambrosio A.4, dell’Insubria, Varese; 2Medicina Interna, Ospedale Sacco,
Clementi M.3, Lazzarin A.2, Tresoldi M.1, Castagna A.2, Milano; 3Dipartimento di Medicina, Università degli Studi di
Scarpellini P.2, Ripa M.2 Verona; 4Dipartimento di Scienze della Salute, Università degli
1General Medicine and Advanced Care Unit, San Raffaele
Studi di Milano; 5Medicina Interna, Ospedale San Paolo,
Hospital, Milano, Italy; 2Department of Infectious Diseases, San Milano; 6Dipartimento di Medicina, Università di Modena e
Raffaele Hospital, Milano, Italy; 3Laboratory of Microbiology Reggio Emilia
and Virology, San Raffaele Hospital, Milano, Italy; 4San Raffaele
Hospital, Milano, Italy LUNG ULTRASOUND IN COVID-19 PATIENTS ADMITTED TO
TWO INTERNAL MEDICINE WARDS
DALBAVANCIN IN BACTERIAL SPONDYLODISCITIS: Barchiesi M.1, Leidi F.1, Russo G.1, Valerio G.1, Casella F.1,
A CASE SERIES Del Medico M.1, Torzillo D.1, Magenta M.2, Zanetti M.2,
Lugarà M., Guida A., De Sena A., Sellitto A., Silvestri N., Samartin F.2, Cogliati C.1
Tirelli P., Madonna P., Oliva G, Coppola MG., Bologna C., 1Medicina ad Indirizzo Fisiopatologico, Ospedale Luigi Sacco,
Turino C., De Luca C., Grasso E. ASST-FBF-Sacco, Milano; 2Medicina Generale, Ospedale Luigi
UOC Medicina Generale PO Ospedale del Mare, ASL Napoli 1 Sacco, ASST-FBF-Sacco, Milano
centro, Napoli
SABATO 24 OTTOBRE 2020 - SALA 3 SABATO 24 OTTOBRE 2020 - SALA 3
PATTERN OF EMERGENCY DEPARTMENT REFERRAL PERFORMANCE OF DIFFERENT PROGNOSTIC SCORE
DURING THE COVID-19 OUTBREAK IN ITALY SYSTEMS IN PREDICTING IN-HOSPITAL MORTALITY IN A
De Benedittis C.1, Bellan M.2, Gavelli F.1, Patrucco F.3, Hayden COHORT OF COVID-19 PATIENTS WITH INTERSTITIAL
E.1, Soddu D.1, Pedrinelli A.R.1, Cittone M.G.1, Rizzi E.1, Casciaro PNEUMONIA ADMITTED TO AN ACUTE MEDICAL UNIT
G.F.1, Vassia V.1, Landi R.1, Menegatti M.4, Gastaldello M.L.1, Accordino S.1, Cazzaniga M.2, Formagnana P.1, Vezza C.1, Cacco
Beltrame M.1, Labella E.1, Tonello S.5, Avanzi G.C.1, Pirisi M.1, S.1, Canetta C.1
Castello L.M.1, Sainaghi P.P.2 1Ospedale Maggiore ASST Crema - UO Medicina Generale e di
1Dipartimento di Medicina Traslazionale, Università del Accettazione e Urgenza; 2Presidio Ospedaliero A. Manzoni
Piemonte Orientale, Novara - Divisioni di Medicina Interna e di ASST Lecco - UO Pronto Soccorso
Medicina d’Urgenza, “AOU Maggiore della Carità”, Novara;
2Dipartimento di Medicina Traslazionale, Università del
Piemonte Orientale, Novara - CAAD, Centre for Autoimmune
and allergic diseases, Novara - Divisioni di Medicina Interna e
di Medicina d’Urgenza, “AOU Maggiore della Carità”, Novara;
3Dipartimento di Medicina Traslazionale, Università del
Piemonte Orientale, Novara; 4Divisioni di Medicina Interna e di
Medicina d’Urgenza, “AOU Maggiore della Carità”, Novara;
5Dipartimento di Medicina Traslazionale, Università del
Piemonte Orientale, Novara - Divisioni di Medicina Interna
OCCURRENCE OF PNEUMOTHORAX IN COVID19 PATIENTS
VENTILATED WITH CPAP
Gidaro A.1, Samartin F.1, Cogliati C.1, Brambilla A.2, Ingrassia S.2,
Cupiraggi V.2, Bonino C.2, Banfi F.2, Merlo A.1, Salvi E.1
1U.O.C. Medicina Generale H. Sacco ASST FBF-Sacco
Milano;2U.O.C. Pronto Soccorso e Medicina D’Urgenza H.
Sacco ASST FBF-Sacco Milano
SABATO 24 OTTOBRE 2020 - SALA 4 SABATO 24 OTTOBRE 2020 - SALA 4
12.30 COMUNICAZIONI ORALI ADHESION-MEDIATED MULTIPLE MYELOMA DISEASE
Moderatori: Carlo Agostini (Padova), Damiano D'Ardes (Chieti) PROGRESSION: CENTRAL FUNCTION FOR JUNCTIONAL
FIBROBLASTS-DERIVED EXOSOMES MEDIATE DRUG ADHESION MOLECULE-A (JAM-A) AND ADAM17 IN
RESISTANCE IN MULTIPLE MYELOMA VIA SELECTIVE miRNA ANGIOGENESIS, MULTIPLE MYELOMA DISSEMINATION
TRANSFER AND CLINICAL PROGNOSIS.
Saltarella I.1, Desantis V.1, Lamanuzzi A.1, Di Marzo L.1, Melaccio Solimando A.G.1, Da Viá M. C.2, Leone P.1, Croci G. A.3, Borrelli
A.1, Curci P.2, Annese T.3, Nico B.3, Ria R.4, Musto P.2, Vacca A.4, P.4, Tabares P.5, Brandl A.5, Malerba E.1, Terragna C.6, Ribatti D.7,
Frassanito M.A.4 Cavo M.6, Racanelli V.1, Einsele H.5, Beilhack A.5, Vacca A.1
1Department of Biomedical Sciences and Human Oncology,
1Department of Biomedical Sciences and Human Oncology
(DIMO), Internal Medicine Section, University of Bari Medical Unit of Internal Medicine “Guido Baccelli”, University of Bari
School, Bari, Italy.; 2Haematology and BMT Unit, University of Aldo Moro Medical School, Policlinico, Bari, Italy; 2Department
Bari Medical School, Policlinico, Italy; 3Department of Basic of Oncology and Hemato-Oncology, University of Milan, Milan,
Medical Sciences, Neurosciences and Sense Organs, University Italy; 3Pathology Unit, Department of Pathophysiology and
of Bari Medical School, Bari, Italy; 4Department of Biomedical Transplantation, University of Milan and Fondazione IRCCS, Ca’
Sciences and Human Oncology (DIMO), Internal Medicine Granda - Maggiore Policlinico, Milan, Italy; 4Department of
Section, University of Bari Medical School, Bari, Italy Medical, Oral and Biotechnological Sciences, Laboratory of
Biostatistics, University “G. d’Annunzio” Chieti-Pescara, Italy;
CLINICAL PRESENTATION OF NON-TRANSFUSION 5Department of Medicine II, University Hospital of Würzburg,
DEPENDENT THALASSEMIA WITH TRIPLICATED a GENES Würzburg, Germany; 6Institute of Hematology “L. and A.
COINHERITED WITH b THALASSEMIA MUTATION Seràgnoli”, Bologna; 7Department of Basic Medical Sciences,
Migone De Amicis M.1, Motta I.2, Marcon A.2, Cassinerio E.1, Neurosciences and Sensory Organs, University of Bari Aldo
Branchi A.2, Maira D.3, Scaramellini N.3, Ferraresi M.3, Moro Medical School, Policlinico, Bari, Italy
Baldini M.1, Cappellini M.D.2, Graziadei G.4
1Fondazione IRCCS Ca’ Granda, Ospedale Maggiore
Policlinico, Dipartimento di Medicina Interna, UOC Medicina
Generale, Milano; 2Università Degli Studi Di Milano,
Dipartimento di Scienze Cliniche e di Comunità; 3Università
degli Studi di Milano, Scuola di Specializzazione in Medicina
Interna; 4Fondazione IRCCS Ca’ Granda, Ospedale Maggiore
Policlinico, Dipartimento di Medicina Interna, UOC Medicina
Generale, Centro Malattie Rare Internistiche, MilanoSABATO 24 OTTOBRE 2020 - SALA 4 SABATO 24 OTTOBRE 2020 - SALA 4
EFFICACY OF CAPLACIZUMAB IN PATIENTS WITH aTTP IN SERUM URIC ACID LEVELS AND THE RISK OF RECURRENT
THE HERCULES STUDY ACCORDING TO BASELINE VENOUS THROMBOEMBOLISM
SEVERITY De Lucchi L.1, Nardin C.1, Sponchiado A.1, Raggi D.2, Callegari
Coppo P.1, Cataland S.2, F. Peyvandi3, Knoebl P.4, Scully M.5, E.1, Cinetto F.1, Agostini C.1, Rattazzi M.1
Kremer Hovinga J. A.6, Metjian A.7, de La Rubia J.8, Pavenski 1Dipartimento di Medicina, DIMED, Università degli Studi di
K.9, De Winter H.10, de Passos Sousa R.11, Callewaert F.12 Padova, Medicina Generale I^, Ospedale Cà Foncello, Treviso;
1Department of Hematology, Reference Center for Thrombotic 2Dipartimento di Economia, Università di Bologna
Microangiopathies (CNR-MAT), SaintAntoine University PLASMA CONCENTRATION OF ACTIVATED FACTOR VII–
Hospital, AP-HP, Paris, France; 2Division of Hematology, ANTITHROMBIN, BUT NOT TISSUE FACTOR PATHWAY
Department of Internal Medicine, The Ohio State University, INHIBITOR AND FACTOR VII LEVELS, PREDICTS MORTALITY
Columbus, OH, USA; 3Angelo Bianchi Bonomi Hemophilia and IN SUBJECTS WITH LIVER AND COLON CANCER
Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale UNDERGOING CURATIVE SURGICAL INTERVENTION.
Maggiore Policlinico, and Department of Pathophysiology and Moruzzi S.1, Castagna A.1, De Santis D.1, Udali S.1, Baroni M.2,
Transplantation, Università degli Studi di Milano, Milan, Italy; Pattini P.1, Ruzzenente A.3, Conci S.3, Campagnaro T.3,
4Department of Medicine 1, Division of Hematology and
Woodhams B.4, Van Dreden P.5, Guglielmi A.3, Bernardi F.2,
Hemostasis, Medical University of Vienna, Vienna, Austria; Oliviero O.1, Friso S.1, Martinelli N.1
5Department of Haematology, University College London
1Department of Medicine, University of Verona, Verona, Italy;
Hospitals, Cardiometabolic Programme, National Institute for 2Department of Life Sciences and Biotechnology, University of
Health Research UCLH-UCL Biomedical Research Center, Ferrara, Ferrara, Italy ; 3Department of Surgery, University of
London, United Kingdom; 6Department of Hematology and Verona, Verona, Italy; 4Haemacon Ltd, Bromley, Kent, United
Central Hematology Laboratory, Inselspital, Bern University Kingdom; 5Clinical Research Department, Diagnostica Stago,
Hospital, University of Bern, Bern, Switzerland; 7Department of Gennevilliers, France
Medicine, Duke University School of Medicine, Durham, NC,
USA; 8Hematology Department, Internal Medicine, School of
Medicine and Dentistry, Catholic University of Valencia and
Hospital Doctor Peset, Valencia, Spain; 9Departments of
Medicine and Laboratory Medicine, St. Michael’s Hospital and
University of Toronto, Toronto, ON, Canada; 10Formerly Clinical
Development, Ablynx, a Sanofi company, Ghent, Oost-
Vlaanderen, BelgiumDOMENICA 25 OTTOBRE 2020 - SALA 1 DOMENICA 25 OTTOBRE 2020 - SALA 1
12.30 COMUNICAZIONI ORALI CLEARANCE OF HEPATITIS C VIRUS BY DIRECT-ACTING
Moderatori: Gaetano F. Mauro (Crotone), Elena Buzzetti (Modena) ANTIVIRALS TREATMENT REDUCES THE INCIDENCE OF
RESPONSE TO TERLIPRESSIN AND ALBUMIN IS TYPE 2 DIABETES MELLITUS. A PROSPECTIVE
ASSOCIATED WITH IMPROVED LIVER TRANSPLANT MULTICENTER STUDY.
OUTCOMES IN PATIENTS WITH HEPATORENAL SYNDROME. Pafundi P.C.1, Nevola R.1, Galiero R.1, Carlo Acierno1,
Piano S.1, Gambino C.1, Vettore E.2, Calvino V.1, Tonon M.1, Caturano A.1, Rinaldi L.1, Petta S.2, Francanzani A.L.3,
Boccagni P.3, Gringeri E.3, Germani G.4, Burra P.4, Cillo U.3, Angeli P.1 Coppola C.4, Narciso V.5, Calvaruso V.2, Lombardi R.3,
1Unit of Internal Medicine and Hepatology (UIMH), Department of Staiano L.4, Di Marco V.2, Solano A.5, Marrone A.1,
Medicine (DIMED), University of Padova, Italy; 2Internal Medicine Saturnino M.4, Rini F.2, Guerrera B.1, Troina G.2, Giordano M.1,
Unit, Ospedale Dell’Angelo, ULSS 3 Serenissima, Mestre, Italy; Craxi A.2, Sasso F.C.1, Adinolfi L.E.1
3Hepatobiliary Surgery and Liver Transplantation, Department of 1University of Campania Luigi Vanvitelli, Department of
Surgery, Oncology and Gastroenterology, University of Padova, Advanced Medical and Surgical Sciences, Naples - Italy.;
Italy; 4Multivisceral Transplant Unit, Department of Surgery, 2University of Palermo, Division of Gastroenterology and
Oncology and Gastroenterology, University of Padova, Italy Hepatology, PROMISE, Palermo, Italy; 3University of Milan,
SAFETY AND EFFICACY OF DIRECT ORAL Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico,
ANTICOAGULANTS IN PATIENTS WITH ADVANCED LIVER Department of Pathophysiology and Transplantation, Italy;
4Gragnano Hospital, ASL Napoli 3 Sud, Unit of Internal Medicine
DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Menichelli D.1, Podda G.2, Pignatelli P.1, Di Rocco A.3, Ronca V.4 and Hepatolology, Gragnano, Napoli, Italy; 5Pellegrini Hospital,
1I Clinica Medica, Atherothrombosis Centre, Department of ASL Napoli 1 Centro, Unit of Hepatology, Naples, Italy
Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, PLATELET AGGREGABILITY AND ENDOTHELIAL
Sapienza University of Rome; 2Medicina 2 ASST Santi Paolo e DYSFUNCTION IN THE DEVELOPMENT OF PORTAL VEIN
Carlo, Dipartimento di Scienze della Salute, Università degli THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS:
Studi di Milano; 3Department of Public Health and Infectious RESULTS FROM THE AGGREGOLIVER STUDY
Diseases, Sapienza University of Rome; 4Division of Cuoghi C.1, Marcacci M.1, Lelli N.2, Marchini S.1, Vegetti A.1,
Gastroenterology, Centre for Autoimmune Liver Disease, Vaccari D.1, Trenti T.2, Pietrangelo A.1, Ventura P.1
European Reference Network on Hepatological Diseases (ERN 1Struttura Complessa di Medicina Interna, Dipartimento di
RARE-LIVER), Department of Medicine and Surgery, University Scienze Mediche e Chirurgiche Materno-Infantili e dell’Adulto,
of Milan-Bicocca Azienda Ospedaliero-Universitaria Policlinico di Modena,
Università degli Studi di Modena e Reggio Emilia; 2Struttura
Complessa Medicina di Laboratorio, Ospedale Civile
Sant’Agostino Estense, Dipartimento Integrato Interaziendale
di Medicina di Laboratorio e Anatomia PatologicaDOMENICA 25 OTTOBRE 2020 - SALA 1 DOMENICA 25 OTTOBRE 2020 - SALA 2
NON-ALCOHOLIC FATTY LIVER DISEASE HAS NOT A 12.30 COMUNICAZIONI ORALI
NEGATIVE PROGNOSTIC VALUE ON SURVIVAL IN THE Moderatori: Paola Andreozzi (Roma), Andrea Dalbeni (Verona)
ELDERLY POPULATION EPICARDIAL ADIPOSE TISSUE INFLAMMATION BUT NOT
Tallarico V., Recinella G., Baietti E., Evangelisti E., Pirazzoli E., OBESITY PREDICTS CLINICAL OUTCOMES IN COVID-19
Zoli M., Bianchi G. Conte C.1, Esposito A.2, De Lorenzo R.3, Di Filippo L.3, Palmisano
Università di Bologna, Policlinico S.Orsola-Malpighi A.3, Vignale D.3, Leone R.3, Nicoletti V.3, Ruggeri A.1, Secchi A.2,
METABOLIC COMORBIDITIES AND OVERWEIGHT FAVOUR Bosi E.2, Tresoldi M.1, Castagna A.2, Landoni G.2, Zangrillo A.2,
NEW ONSET STEATOSIS AND PREVENT STEATOSIS Decobelli F.2, Ciceri F.2, Camici P.2, Rovere Querini P.2
RESOLUTION AFTER VIRAL ERADICATION IN PATIENTS 1IRCCS San Raffaele Hospital, Milan; 2Vita-Salute San Raffaele
WITH CHRONIC HEPATITIS C TREATED BY DIRECT-ACTING University and IRCCS San Raffaele Hospital, Milan; 3Vita-Salute
ANTIVIRAL THERAPY: EVALUATION BY CONTROLLED San Raffaele University, Milan
ATTENUATION PARAMETER (CAP) RELATIONSHIP BETWEEN HYPOALBUMINEMIA AND
Cespiati A.1, Lombardi R.1, Petta S.2, Sigon G.1, Pisano G.1, Fatta COAGULOPATHY IN HOSPITALIZED COVID-19 PATIENTS.
E.1, Bertelli C.1, Fracanzani A.L.1 Wu M.A.1, Taino A.1, Trombetta L.1, Passeri M.2, Facchinetti P.1,
1Department of Pathophysiology and Transplantation Ca’
Giaretta M.2, Lazzari B.2, Marchetti A.1, Messina V.2, Arquati M.3,
Granda IRCCS Foundation, Policlinico Hospital, University of Colombo R.2, Cogliati C.1
Milan; 2Sezione di Gastroenterologia e Epatologia, Di.Bi.M.I.S., 1Division of Internal Medicine, ASST Fatebenefratelli Sacco,
University of Palermo, Italy Luigi Sacco Hospital, University of Milan, Milan, Italy; 2Division
of Anesthesiology and Intensive Care, ASST Fatebenefratelli
Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy;
3Division of Emergency Medicine, ASST Fatebenefratelli Sacco,
Luigi Sacco Hospital, University of Milan, Milan, Italy
HAEMOSTATIC CHANGES IN PATIENTS WITH COVID-19:
A META-ANALYSIS WITH META-REGRESSIONS
Calcaterra I.1, Lupoli R.2, Forte F.1, Vitelli N.1, Di Minno A.3,
Ambrosino P.4, Di Minno M.N.D5
1Department of Clinical Medicine and Surgery, Federico II University,
Naples, Italy; 2Department of Molecular Medicine and Medical
Biotechnologies, Federico II University, Naples, Italy; 3Department of
Pharmacy, Federico II University, Naples, Italy; 4Istituti Clinici
Scientifici Maugeri IRCCS, Pavia, Italy; 5Department of Translational
Medical Sciences, Federico II University, Naples, ItalyDOMENICA 25 OTTOBRE 2020 - SALA 2 DOMENICA 25 OTTOBRE 2020 - SALA 3
SYMPTOMS OF COVID-19 IN KIDNEY AND/OR BETA CELL 12.30 COMUNICAZIONI ORALI
TRANSPLANT RECIPENTS: A REPORT FROM THE INTERNAL Moderatori: Antonino Saitta (Messina), Sara Bianco (Novara)
MEDICINE AND TRANSPLANTATION UNIT – IRCCS SAN IMPROVING THE PREDICTION OF IN-HOSPITAL DEATH
RAFFAELE HOSPITAL FOR AHF ADOPTING EHMRG SCORE AND
Catarinella D.1, Secchi A.1, Conte C.1, Caldara R.2, Gremizzi C.2, ECHOCARDIOGRAPHY IN THE EMERGENCY DEPARTMENT
Tentori S.2, Paloschi V.2, Lepore M.2, Pomaranzi C.1, Maffi P.2 Giovenali L.1, Falsetti L.2, Consuelo F.1, Zaccone V.2,
1Università Vita-Salute San Raffale - Milano; 2IRCCS San
Sampaolesi M.1, Morciano P.1, Moroncini G.3, Fioranelli A.4,
Raffaele, Milano Viticchi G.5, Martino M.6, Scalpelli C.4, Burattini M.4,
PULMONARY FUNCTION IN COVID-19 SURVIVORS: DATA Tarquinio N.4
FROM ONE-MONTH FOLLOW-UP 1Emergency Medicine Residency Program, Marche Polytechnic
Ferrante M.1, Calcaterra B.2, Falbo E.3, Cinel E.3, De Lorenzo R.3, University, Ancona, Italy; 2Internal and Subintensive Medicine
Patrizi A.3, Cilla M.3, Castellani J.3, Compagnone N.3, Conte C.2, Department, Azienda Ospedaliero-Universitaria “Ospedali
Bosi E.4, Mariani F.2, Rovere Querini P.5 Riuniti” di Ancona, Italy; 3Clinica Medica, Azienda Ospedaliero-
1Vita-Salute San Raffaele University, Milan, Italy; 2IRCCS San Universitaria “Ospedali Riuniti” di Ancona, Italy, Ancona, Italy;
Raffaele Hospital, Milan, Italy; 3Vita-Salute San Raffaele 4Internal Medicine Department, INRCA-IRCCS Hospital, Osimo
University, Milan, Italy; 4IRCCS San Raffaele Hospital, Milan, (Ancona); 5Clinica di Neurologia, Azienda Ospedaliero-
Italy; Vita-Salute San Raffaele University, Milan, Italy; 5IRCCS Universitaria “Ospedali Riuniti” di Ancona, Italy; 6Clinica di
San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele Endocrinologia, Azienda Ospedaliero-Universitaria “Ospedali
University, Milan, Italy Riuniti” di Ancona, Italy
HOMEDOC: HELPING PHYSICIANS DURING THE COVID19 HUMAN SERUM ALBUMIN AND MAJOR ADVERSE
CRISIS THROUGH AN EHEALTH PLATFORM AND MACHINE CARDIOVASCULAR EVENTS IN PATIENTS WITH ISCHEMIC
LEARNING. HEART DISEASE: INSIGHTS FROM THE ENDOCRINE
Montagna M.1, Battezzati N.2, Guidotti R.3, Cavallone A.4, VASCULAR DISEASE APPROACH STUDY
Masino P.2, Calzolai L.2 Recchia F.1, Romiti G.F.1, Rozzi G.1, Corica B.1, Cangemi R.1,
1Vita-Salute San Raffaele University; 2HomeDoc.it; 3Department Stefanini L.1, Viceconte N.2, Tanzilli G.2, Proietti M.3, Basili S.1,
of Computer Science, Aalto University, Espoo, Finland e Raparelli V.4, Eva Investigators5
Department of Neuroscience, Imaging and Clinical Sciences, 1Department of Translational and Precision Medicine, Sapienza
University “G. D’Annunzio”, Chieti, Italy; 4Altran Italia University of Rome, Rome, Italy; 2Department of Cardiovascular
Sciences, Sapienza University of Rome, Rome, Italy;
3Department of Clinical Sciences and Community Health,
University of Milan, Milan, Italy; 4Department of Experimental
Medicine, Sapienza University of Rome, Rome, Italy; 5Sapienza
University of Rome, Rome, ItalyDOMENICA 25 OTTOBRE 2020 - SALA 3 DOMENICA 25 OTTOBRE 2020 - SALA 3
SERUM LEVELS OF BRAIN-DERIVED NEUROTROPHIC 1Centre for Pulmonary Hypertension, Thoraxklinik Heidelberg
FACTORS IN PATIENTS WITH CHRONIC HEART FAILURE: gGmbH at Heidelberg University Hospital, Translational Lung
THE ROLE OF b3-ADRENERGIC RECEPTOR VARIANTS Research Center Heidelberg (TLRC), German Center for Lung
Gambino G.1, Bencivenga L.1, Liccardo D.1, Cuocolo A.2, Research (DZL), Heidelberg, Germany; 2Scottish Pulmonary
Perrone Filardi P.2, Vitale F.D.3, Cannavo A.1, Ferrara N.1, Rengo G.1 Vascular Unit, Golden Jubilee National Hospital, Glasgow,
1Dipartimento di Scienze Mediche Traslazionali, Università degli United Kingdom; 3Rehabilitation Center Koenigstuhl,
Studi di Napoli “Federico II’’; 2Dipartimento di Scienze Heidelberg, Germany; 4Clinic of Pulmonology, University
Biomediche Avanzate Università degli Studi di Napoli Hospital and University of Zurich, Zurich, Switzerland; 5Cardiac
“Federico II’’; 3Istituti Clinici Scientifici ICS Maugeri S.p.A. Rehabilitation Department, IRCCS Maugeri Clinical Scientific
IRCCS, Istituto Scientifico di Telese Terme Institutes, Milan, Italy ; 6Divisione di Cardiologia, Fondazione
LONG-TERM EFFECTS OF SACUBITRIL-VALSARTAN IRCCS Policlinico S Matteo, Pavia, Italy; 7Institute of Clinical
TREATMENT ON METABOLIC AND CARDIOVASCULAR Medicine, Faculty of Medicine, Vilnius University, Vilnius,
PARAMETERS IN ELDERLY PATIENTS WITH HEART FAILURE Lithuania; 8Department of Clinical Medicine and Surgery,
WITH REDUCED EJECTION FRACTION - REAL LIFE DATA Federico II University, Naples, Italy; 9Department of Internal
Armentaro G., Toscani A.F., Magurno M., Suraci E., Medicine, Div. Pulmonology, Medical University of Graz, Graz,
Volpentesta M., Cassano V., Battaglia R., Filicetti E., Pinto A., Austria; 10Department of Pulmonary Medicine, Hospital Clinic-
Maio R., Miceli S., Perticone F., Sciacqua A. IDIBAPS, University of Barcelona, Barcelona and Biomedical
Department of Medical and Surgical Sciences, University Magna Research Networking Center on Respiratory Diseases
Græcia of Catanzaro (CIBERES), Spain; 11Research and Devlopment, Ciro, Horn,
Netherlands; Department of Respiratory Medicine, Maastricht ;
STANDARDISED EXERCISE TRAINING IS FEASIBLE, SAFE 12Department of Research and Education, CIRO, Horn, The
AND EFFECTIVE IN PULMONARY ARTERIAL AND CHRONIC Netherlands; 13Amsterdam UMC, VU University Medical Center,
THROMBOEMBOLIC PULMONARY HYPERTENSION - Department of Pulmonology, Amsterdam Cardiovascular
RESULTS FROM A LARGE EUROPEAN MULTICENTRE Sciences, 1081 BT Amsterdam, The Netherlands; 14Department
RANDOMISED CONTROLLED TRIAL of Internal Medicine, Hospital Geral de Santo António, Porto,
Marra A.M.1, MacKenzie A.2, Peacock A.J.2, Eichstaedt C.1, Portugal; 15Centro de Rehabilitação do Norte, Porto, Portugal;
Benjamin N.1, Nechwatal R.3, Ulrich S.4, Saxer S.4, Bussotti M.5, 16Department of Pneumology, University Hospital Leuven,
Sommaruga M.5, Ghio S.6, Gumbiene L.7, E. Paleviciute7, E. Leuven, Belgium; 17Department of Cardiology, Antonio
Jureviciene7, Stanziola A.A.8, Kovacs G.9, Olschewski H.9, Cardarelli Hospital, Naples, Italy; 18Department of Translational
Barberà J.A.10, Blanco I.10, Spruit M.A.11, Franssen F.M.E.12, Vonk Medical Sciences, “Federico II” University Hospital and School
Noordegraaf A.13, Reis A.14, Santos M.15, Gonçalves Viamonte of Medicine, Naples, Italy
S.15, Demeyer H.16, Delcroix M.16, Johnson M.2, Bossone E.17,
Cittadini A.18, Gruenig E.1DOMENICA 25 OTTOBRE 2020 - SALA 3 DOMENICA 25 OTTOBRE 2020 - SALA 4
THE PREDICTIVE ROLE OF EDUCATION ATTAINMENT LEVEL 12.30 COMUNICAZIONI ORALI
IN INDIVIDUALS WITH ISCHEMIC HEART DISEASE: ANALYSIS Moderatori: Elsa Berardi (Bari), Vincenzo Zaccone (Ancona)
FROM THE ENDOCRINE VASCULAR DISEASE APPROACH STUDY
COULD PET/CT BE THE FIRST CHOICE FOR DIFFERENTIAL
Raparelli V.1, Tucci C.2, Proietti M.3, Santomenna F.2, Lenzi A.1,
DIAGNOSIS OF FEVER OF FUO/IUO?
Viceconte N.4, Tanzilli G.4, Corica B.2, Romiti G.F.2, Basili S.2,
Tagliente T.1, Malandrino D.1, Allocca M.2, Olianti C.2,
EVA Investigators5
1Department of Experimental Medicine, Sapienza University of Poggesi L.1, Berni A.3
1Department of Experimental and Clinical Medicine, University
Rome, Italy; 2Department of Translational and Precision Medicine,
of Firenze; 2Nuclear Medicine Unit, Department of Experimental
Sapienza University of Rome, Italy; 3Department of Clinical
Sciences and Community Health, University of Milan, Italy; and Clinical Biomedical Sciences “Mario Serio”, University of
4Department of Cardiovascular Sciences, Sapienza University of Florence; 3Internal Medicine Unit 3, Careggi University
Rome, Italy; 5Sapienza University of Rome, Italy Hospital, Firenze, Italy
THREE-MONTH MORTALITY IN PERMANENTLY BEDRIDDEN
MEDICAL NON-ONCOLOGIC PATIENTS. THE BECLAP
STUDY (PERMANENTLY BEDRIDDEN, CREATININE
CLEARANCE, ALBUMIN, PREVIOUS HOSPITAL
ADMISSIONS STUDY)
Cumetti D.F.1, Tiraboschi M.M.1, Cogliati C.2, Squizzato A.3,
Pasina L.4, Tognoni G.5, Barbui T.6, Brucato A.L.7
1Medicina interna, ASST Papa Giovanni XXIII Bergamo;
2Dipartimento di Medicina, Ospedale L. Sacco Milano;
3Dipartimento di Medicina e Chirurgica, Università Insubria
Varese; 4IRCCS Mario Negri Milano; 5Dipartimento Anestesia-
rianimazione e emergenza urgenza, Ospedale Maggiore
Policlinico Milano; 6Fondazione FROM Ricerca, ASST Papa
Giovanni XXIII Bergamo; 7Dipartimento di scienze biomediche
e cliniche, Università degli studi di Milano, Ospedale
FatebenefratelliDOMENICA 25 OTTOBRE 2020 - SALA 4 DOMENICA 25 OTTOBRE 2020 - SALA 4
PREDICTIVE FACTORS FOR RENAL DISEASE PROGRESSION VERTEBRAL FRACTURE ASSESSMENT IN
IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY POSTMENOPAUSAL WOMEN WITH POST-SURGICAL
DISEASE (COPD) HYPOPARATHYROIDISM
Critelli R.1, Pastori D.2, Pelaia C.1, Barbara K.1, Scalise L.1, Cipriani C.1, Diacinti D.2, Pepe J.1, Diacinti D.3, Colangelo L.1,
Cassano V.1, Caroleo B.1, Perticone M.1, Pignatelli P.2, Violi F.2, Piazzolla V.1, Angelozzi M.2, Nieddu L.4, Minisola S.1
Sesti G.3, Perticone F.1, Sciacqua A.1 1Department of Clinical, Internal, Anesthesiology and
1Department of Medical and Surgical Sciences, University Cardiovascular Sciences, Sapienza University of Rome, Italy;
Magna Græcia of Catanzaro; 2Department of Clinical Internal, 2Department of Radiological Sciences, Oncology and
Anesthesiologic, and Cardiovascular Sciences, Sapienza Pathology, Sapienza University of Rome, Italy; 3Department of
University of Rome; 3Department of Clinical and Molecular Oral and Maxillo-Facial Sciences, Sapienza University of Rome,
Medicine, University of Rome-Sapienza Italy; Department of Diagnostic and Molecular Imaging,
RENAL FUNCTION, INAPPROPRIATE DRUG PRESCRIPTION Radiology and Radiotherapy, University Tor Vergata, Rome,
AND CLINICAL OUTCOMES IN HOSPITALIZED ELDERLY: Italy; 4Faculty of Economics, UNINT University, Rome, Italy
DATA FROM THE REPOSI REGISTRY
Gigante A.1, Proietti M.2, Petrillo E.1, Mannucci P.M.3, Nobili A.4,
Muscaritoli M.1
1Department of Translational and Precision Medicine, Sapienza
University of Rome, Italy; 2Department of Clinical Sciences and
Community Health, University of Milan, Italy; 3Scientific
Direction, Fondazione IRCCS Ca’ Granda Ospedale Maggiore
Policlinico, Milan, Italy; 4Department of Neuroscience, Istituto
di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
PROMINENT INVOLVEMENT OF BASAL LEFT VENTRICULAR
LONGITUDINAL STRAIN IN PATIENTS WITH MONOCLONAL
GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Canonico M.E.1, Fiorillo L.2, Santoro C.1, Esposito L.1,
Capone V.1, Casciano O.1, Cuomo V.2, Fedele T.2, Orefice S.2,
Esposito R.2
1Dipartimento di Scienze Biomediche Avanzate, AOU Federico
II, Napoli; 2Dipartimento di Medicina Clinica e Chirurgia, AOU
Federico II, NapoliPuoi anche leggere
